Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytes (original) (raw)

Tumor blood vessels, a difficult hurdle for infiltrating leukocytes

Arjan Griffioen

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2007

View PDFchevron_right

Leukocyte trafficking in tumor microenvironment

Tiziana SCHIOPPA

Current opinion in pharmacology, 2017

View PDFchevron_right

Won’t you come on in? How to favor lymphocyte infiltration in tumors

Matteo Bellone

OncoImmunology, 2012

View PDFchevron_right

Normalizing Tumor Vasculature to Reduce Hypoxia, Enhance Perfusion, and Optimize Therapy Uptake

Duncan Petrik

Cancers, 2021

View PDFchevron_right

Modification of tumor blood flow: Current status and future directions

Gillian Tozer

Seminars in Radiation Oncology, 1998

View PDFchevron_right

T-Cell Trafficking Facilitated by High Endothelial Venules Is Required for Tumor Control after Regulatory T-Cell Depletion

Sarah Lauder

Cancer Research, 2012

View PDFchevron_right

Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies

Claudine Kieda

Frontiers in Immunology, 2021

View PDFchevron_right

Targeting TNF- to Neoangiogenic Vessels Enhances Lymphocyte Infiltration in Tumors and Increases the Therapeutic Potential of Immunotherapy

Matteo Bellone

The Journal of Immunology, 2012

View PDFchevron_right

Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors

Kevin Mayo

The FASEB Journal, 2006

View PDFchevron_right

Perspectives on Vascular Regulation of Mechanisms Controlling Selective Immune Cell Function in the Tumor Immune Response

michael welsh

International Journal of Molecular Sciences, 2022

View PDFchevron_right

Interaction of tumor cells and lymphatic vessels in cancer progression

Carlos Pablo

View PDFchevron_right

Failure of anti tumor-derived endothelial cell immunotherapy depends on augmentation of tumor hypoxia

Michele Cilli

Oncotarget, 2014

View PDFchevron_right

Targeting TNF-α to Neoangiogenic Vessels Enhances Lymphocyte Infiltration in Tumors and Increases the Therapeutic Potential of Immunotherapy

Angelo Corti

The Journal of Immunology, 2012

View PDFchevron_right

TRAIL-coated leukocytes that kill cancer cells in the circulation

Kuldeepsinh Rana

Proceedings of the National Academy of Sciences of the United States of America, 2014

View PDFchevron_right

High Endothelial Venule Blood Vessels for Tumor-Infiltrating Lymphocytes Are Associated with Lymphotoxin β–Producing Dendritic Cells in Human Breast Cancer

I. Garrido

The Journal of Immunology, 2013

View PDFchevron_right

The mechanistic immunosuppressive role of the tumour vasculature and potential nanoparticle-mediated therapeutic strategies

Jale Yuzugulen

Frontiers in Immunology

View PDFchevron_right

Diminished leukocyte-endothelium interaction in tumor microvessels

Bruce Klitzman

Cancer research, 1992

View PDFchevron_right

Cancer Cells Regulate Lymphocyte Recruitment and Leukocyte-Endothelium Interactions in the Tumor-Draining Lymph Node

R. Colisson

Cancer Research, 2005

View PDFchevron_right

The relationship between tumor blood flow, angiogenesis, tumor hypoxia, and aerobic glycolysis

Kim Drasbek, Leif Østergaard, Anna Tietze, Sune Jespersen

Cancer research, 2013

View PDFchevron_right

Enhancement of T-cell–Mediated Antitumor Response: Angiostatic Adjuvant to Immunotherapy against Cancer

Arjan Griffioen

Clinical Cancer Research, 2011

View PDFchevron_right

Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment

Susan Hobbs

Proceedings of the National Academy of Sciences, 1998

View PDFchevron_right

The Cancer Cell Dissemination Machinery as an Immunosuppressive Niche: A New Obstacle Towards the Era of Cancer Immunotherapy

David Entenberg

Frontiers in Immunology, 2021

View PDFchevron_right

Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment

Niranjan Pandey

Expert Reviews in Molecular Medicine, 2015

View PDFchevron_right

Crosstalk between Blood Vessels and Tumor Microenvironment

Kyoko Hida

Oral Science International, 2010

View PDFchevron_right

Leukocyte Infiltration in Cancer Creates an Unfavorable Environment for Antitumor Immune Responses: A Novel Target for Therapeutic Intervention

Sara Cingarlini

Immunological Investigations, 2006

View PDFchevron_right

Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy

fabrizio vianello

Proceedings of the National Academy of Sciences, 2012

View PDFchevron_right

Vascular Permeability and Drug Delivery in Cancers

jagoda hebda

Frontiers in Oncology, 2013

View PDFchevron_right

Crosstalk between medulloblastoma cells and endothelium triggers a strong chemotactic signal recruiting T lymphocytes to the tumor microenvironment

Xiuhua Gao

PloS one, 2011

View PDFchevron_right

Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming

Chenghang Zong

Nature, 2017

View PDFchevron_right

Tumor Hypoxia and Circulating Tumor Cells

Walter Tinganelli

International Journal of Molecular Sciences, 2020

View PDFchevron_right

Static and Dynamic Interactions between Endothelium and Circulating Cells in Cancer

C. Verdier

View PDFchevron_right

Lymphatic vessel activation in cancer

Suvendu Das

Annals of The New York Academy of Sciences, 2008

View PDFchevron_right

Enhancement of fluid filtration across tumor vessels: implication for delivery of macromolecules

Paolo A Netti

Proceedings of the National Academy of Sciences of the United States of America, 1999

View PDFchevron_right

Alternative Vascularization Mechanisms in Cancer

József Tóvári

The American Journal of Pathology, 2007

View PDFchevron_right